Cell Therapy, Leadership November 04, 2024 RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer
Cell and Gene Therapy, Cell Therapy, Leadership June 25, 2024 RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
Cell and Gene Therapy, Leadership March 07, 2024 Governor Healey Highlights Life Sciences Investments from Mass Leads Act in Worcester and Hopkinton
Cell and Gene Therapy, Leadership December 07, 2023 Ian McCubbin receives Peter Dunnill award at bioProcessUK
Cell and Gene Therapy, Leadership October 04, 2023 RoslinCT to Present at 2023 Cell & Gene Meeting on the Mesa
Cell and Gene Therapy, Leadership October 03, 2023 RoslinCT Boston Appoints Dean J. Morris, as Chief Operations Officer
Leadership, New cGMP suites, Partnerships, Site Expansion February 23, 2023 RoslinCT and Lykan Bioscience Announce the Addition of Six cGMP Suites to Meet Growing Demand
Leadership, Partnerships, Scientific Advisor January 10, 2023 RoslinCT and Lykan Bioscience Announce the Appointment of Dr. Michael Mendicino to its Scientific Advisory Board